← Back to Patent Explorer
US5362756A Expired / Lapsed US ⏱️ 0.0 years remaining

Use of fedotozine in the treatment of functional states of intestinal obstructions

Assignee: Jouveinal SA
•
Filing: 1992-08-31
•
Granted: 1994-11-08
•
Expires: 2012-08-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for inhibiting functional ileus in a patient, which consists of administering a therapeutically effective dose of (+)-1-1[(3,4,5-trimethoxy)benzyloxymethyl]-1-phenyl-N,N dimethylpropylamine or the addition salt thereof with (-)-tartaric acid is disclosed.

Inventors

  • 👤 Pierre J. M. Riviere
  • 👤 Xavier B. Pascaud
  • 👤 Francois J. Roman
  • 👤 Jean-Louis Junien

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 00:42
CPC Classifications
C; C07; C07C; C07C217/00; C07C217/02; C07C217/48

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 26 words
Process for inhibiting functional ileus in a patient, which consists of administering a therapeutically effective dose of (+)-1-[(3,4,5-trimethoxy)benzyloxymethyl]-1-phenyl-N,N-dimethylpropylamine or the addition salt thereof with (-)-tartaric acid.
Claim 2
Dependent Claim 26 words
Process for inhibiting functional ileus in a patient, which consists of administering a therapeutically effective dose of (+)-1-[(3,4,5-trimethoxy)benzyloxymethyl]-1-phenyl-N,N-dimethylpropylamine or the addition salt thereof with (-)-tartaric acid.
Claim 3
Dependent Claim 12 words
Process according to claim 1, in which the functional ileus is postoperative.
Claim 4
Dependent Claim 14 words
Process according to claim 1, in which the functional ileus is of pseudo-obstructive origin.
Claim 5
Dependent Claim 20 words
Process according to claim 1 which consists in administering a daily dose of 5 to 1000 mg to the patient.
Claim 6
Dependent Claim 13 words
Process according to claim 1, which consists in administering the substance by injection.
Claim 7
Dependent Claim 13 words
Process according to claim 1, which consists in administering the substance by perfusion.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-11-07 1998-05-09 1998-11-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-11-07 2002-05-09 2002-11-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-11-07 2006-05-09 2006-11-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag